Vikram Sudarsan
Chief Executive Officer at Engrail Therapeutics, Inc.
Vikram Sudarsan active positions
| Companies | Position | Start | End |
|---|---|---|---|
Engrail Therapeutics, Inc.
 Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 30/06/2019 | - |
| Chief Executive Officer | 30/06/2019 | - | |
| President | 30/06/2019 | - |
Career history of Vikram Sudarsan
Former positions of Vikram Sudarsan
| Companies | Position | Start | End |
|---|---|---|---|
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Director/Board Member | 11/05/2014 | - |
Statistics
International
| United States | 3 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Health Technology |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Vikram Sudarsan
- Experience
